PitchCentric
Oncology Learning Network podcast artwork

Health

Oncology Learning Network

Health · EN

Website

About this Podcast:

Podcast by HMP Global

Pitch Analysis

Required Pod Score for this podcast. PitchCentric checks your profile against host openness, topical fit, and audience signals before you generate a pitch.

Contact path

Public web form

Booking probability

43%

Guest openness

Selective

80/100
Required Score

Sign up to generate a grounded pitch for Oncology Learning Network.

Signup to Generate a Pitch

Questions about Oncology Learning Network

What has Oncology Learning Network covered recently?

Recent episodes include "Immune Checkpoint Inhibition in Advanced cSCC: Perspectives From Clinical Practice" (13 October 2026, 11 minutes), "Immune Checkpoint Inhibition in Advanced cSCC: Perspectives From Clinical Practice" (29 September 2026, 12 minutes), and "Immune Checkpoint Inhibition in Advanced cSCC: Perspectives From Clinical Practice" (21 September 2026, 14 minutes).

How often does Oncology Learning Network publish?

Oncology Learning Network publishes roughly every two weeks, with episodes averaging 8 minutes across 190 episodes.

How hard is it to get booked on Oncology Learning Network?

Booking probability for Oncology Learning Network is 43%, and the host is rated Selective on guests. Oncology Learning Network requires a Pod Score of 80 or higher. Oncology Learning Network's contact route on record: public web form.

Who should pitch Oncology Learning Network?

The strongest fits for Oncology Learning Network are Health & Wellness Services and Courses, Coaching & Lessons. Oncology Learning Network has a health audience.

About the host

Oncology Learning Network is a health podcast with 190 episodes published.

Host email not verified for this podcastSign in to unlock →

Recent episodes

Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.

  • Oncology Learning Network

    Immune Checkpoint Inhibition in Advanced cSCC: Perspectives From Clinical Practice

    Oct 13, 202611 min

    In this podcast, David Portnoy, MD, a medical oncologist at the West Cancer Center and Research Institute in Memphis, Tennessee, discusses how he approaches treatment selection for patients with advanced cutaneous...

  • Oncology Learning Network

    Immune Checkpoint Inhibition in Advanced cSCC: Perspectives From Clinical Practice

    Sep 29, 202612 min

    In this expert discussion, Bahar Dasgeb, MD, shares a patient-centered approach to treatment selection for advanced cutaneous squamous cell carcinoma, including how disease characteristics, autoimmune and inflammatory...

  • Oncology Learning Network

    Immune Checkpoint Inhibition in Advanced cSCC: Perspectives From Clinical Practice

    Sep 21, 202614 min

    In this podcast, Omid Hamid, MD, discusses how clinicians can individualize treatment selection for patients with advanced cutaneous squamous cell carcinoma based on factors such as age, performance status...

  • Oncology Learning Network

    Preparing for Biomarker-Directed Care in epNEC: What Pathologists Need to Know Now

    Aug 26, 202612 min

    This podcast features Dr David Klimstra discussing how pathologists can prepare for biomarker-directed care in extrapulmonary neuroendocrine carcinoma (epNEC). Key topics include accurate NEC classification before...

  • Oncology Learning Network

    Artificial Intelligence for Skin Cancer Diagnosis

    Aug 4, 202612 min

    Luc Thomas, MD, PhD, discusses findings from a real-world study comparing artificial intelligence models with clinicians for skin cancer diagnosis, highlighting the strengths and limitations of artificial intelligence...

View More
  • Oncology Learning Network

    Connecting the Dots: How MET Fits Into Comprehensive Molecular Profiling

    Jul 14, 20264 min

    Dr Jamie Chaft reviews the biological and clinical differences among MET biomarkers in NSCLC, emphasizing the importance of matching the specific biomarker question to the appropriate assay. The discussion covers NGS...

  • Oncology Learning Network

    Testing Matters: Practical Approaches to Biomarker Evaluation in NSCLC

    Jul 14, 20267 min

    Dr Jamie Chaft reviews the importance of early tissue stewardship in NSCLC, including how biopsy planning, tissue adequacy, and coordination across the care team can influence biomarker testing and treatment planning...

  • Oncology Learning Network

    Real-World Decision Points in Biomarker-Driven NSCLC Management

    Jul 14, 20265 min

    Dr Jamie Chaft discusses how longitudinal biomarker assessment can support treatment planning, resistance evaluation, and rebiopsy decision-making in NSCLC. Key topics include disease progression, tissue limitations...

  • Oncology Learning Network

    Beyond FVC: What FIBRONEER-ILD Means for Outcomes, Patients, and Access in PPF

    Jul 14, 202617 min

    In this expert commentary, Toby Maher, MD, PhD, discusses the evolving treatment landscape in progressive pulmonary fibrosis (PPF) and the potential implications of the longer-term FIBRONEER-ILD trial findings. He...

  • Oncology Learning Network

    Tafasitamab Plus Lenalidomide Improves Frontline Outcomes in High-Risk Diffuse Large B-Cell Lymphoma

    Jul 8, 20267 min

    Umberto Vitolo, MD, discusses results from the phase 3 FrontMIND trial showing that adding tafasitamab and lenalidomide to R-CHOP significantly improved progression-free survival in patients with newly diagnosed...

  • Oncology Learning Network

    Closing the Gap Between CAR T–Cell Therapy Recognition and Referral in Multiple Myeloma

    Jun 22, 202613 min

    Samantha Shenoy, NP, and Caitlin Costello, MD, discuss how oncology care teams can close the gap between recognizing a patient with multiple myeloma as a potential CAR T-cell therapy candidate and getting that patient...

  • Oncology Learning Network

    When to Raise the Question of CAR T–Cell Therapy in Multiple Myeloma

    Jun 22, 20269 min

    Samantha Shenoy, NP, and Caitlin Costello, MD, discuss how risk stratification, early relapse patterns, and changes in disease trajectory can help oncology care teams recognize when a patient with multiple myeloma may...

  • Oncology Learning Network

    Olverembatinib Plus Blinatumomab Produces Deep Responses in Ph+ Acute Lymphoblastic Leukemia

    Jun 5, 20264 min

    Elias Jabbour, MD, MD Anderson Cancer Center, Houston, Texas, discusses results from a phase 1 study showing that olverembatinib plus blinatumomab induced high response rates and deep MRD-negative remissions in heavily...

  • Oncology Learning Network

    How is ctDNA MRD Testing Used in Lymphoma Care?

    Jun 4, 20269 min

    This podcast examines the clinical utility of ctDNA-based MRD testing in diffuse large B-cell lymphoma, focusing on its role in post-treatment risk stratification, relapse detection, and treatment decision-making. Dr...

  • Oncology Learning Network

    How Are We Detecting Residual Disease in Lymphoma Today?

    Jun 4, 20269 min

    This podcast explores the principles and clinical applications of circulating ctDNA-based MRD testing in diffuse large B-cell lymphoma, including how personalized sequencing assays can detect microscopic residual...

  • Oncology Learning Network

    How Are We Detecting Residual Disease in Lymphoma Today?

    Jun 4, 20269 min

    This podcast reviews current and emerging approaches to residual disease detection in diffuse large B-cell lymphoma, emphasizing the role of PET-CT imaging in assessing treatment response and predicting relapse risk...

  • Oncology Learning Network

    Treatment of Recurrent Refractory Pediatric Low-Grade Glioma (pLGG)

    Dec 30, 20259 min

    Guest host Cassie Kline, MD, MAS, presents a three-year update from the phase 2 FIREFLY-1 trial evaluating tovorafenib, a weekly oral type II RAF inhibitor, in recurrent or refractory pediatric low-grade glioma. She...

  • Oncology Learning Network

    Navigating The Complexity of Melanoma Care: Part 6

    May 21, 20252 min
  • Oncology Learning Network

    Navigating The Complexity of Melanoma Care: Part 5

    May 21, 20252 min
  • Oncology Learning Network

    Navigating The Complexity of Melanoma Care: Part 4

    May 21, 20253 min

Recent guests

Recent guests on Oncology Learning Network. Study who booked and why before you pitch.

Best industries to pitch Oncology Learning Network for

PitchCentric classifies Oncology Learning Network under these industries. Guests from them are the closest fit, and each links to the best podcasts in that industry.

Similar Podcasts

Shows with the most semantically similar episode content. Pitch one, pitch all; producers cluster.

Podcasts like Oncology Learning Network

Is this podcast yours and you'd like to remove or correct details? Request removal or email privacy@pitchcentric.com.

Questions about the free trial? See the pricing FAQ